Heart disease and stroke remain the world’s leading causes of death, yet the adoption of life-saving health technologies often lags behind innovation. But what if we could bridge this gap and save millions of lives? The American Heart Association® is taking a bold step forward by announcing the finalists of its 8th annual Health Tech Competition, a platform designed to spotlight groundbreaking solutions in cardiovascular and brain health. Hosted by the Center for Health Technology & Innovation, this competition isn’t just about ideas—it’s about transforming them into real-world impact.
Here’s where it gets exciting: Five innovative companies have been selected to present their cutting-edge technologies at the Scientific Sessions 2025, the American Heart Association’s flagship global event. These finalists are tackling some of the most pressing challenges in heart and brain health, from stroke diagnosis to congenital heart disease in children. Let’s meet the contenders:
- Brainomix (Oxford, England): Revolutionizing stroke care with AI-powered software that enhances diagnosis and treatment decisions.
- Cambrian Health (San Francisco): Ensuring clinical best practices are seamlessly integrated into patient care through an AI-driven platform.
- Lumia (Boston): Developing wearable solutions for individuals with orthostatic intolerance and chronic blood flow disorders.
- Noah Labs (Berlin): Turning voice into a digital biomarker to enable early intervention for cardiometabolic diseases.
- PolyVascular (Houston, Texas): Creating minimally invasive solutions for children with congenital heart disease, reducing the need for repeated open-heart surgeries.
And this is the part most people miss: These innovations aren’t just about technology—they’re about transforming lives. The finalists will present live at the New Orleans Ernest N. Morial Convention Center on November 8–9, where a panel of esteemed judges will evaluate their solutions based on validity, scientific rigor, and impact. The winner will join the Center for Health Technology & Innovation’s Innovators’ Network, a collaborative hub connecting entrepreneurs, providers, and researchers to drive cardiovascular and brain health innovation.
But here’s where it gets controversial: How do we ensure these technologies reach those who need them most? While innovation is booming, accessibility remains a challenge. The American Heart Association emphasizes the importance of evidence-based solutions, but what role should corporations play in funding these advancements? The Association prides itself on maintaining strict policies to prevent corporate influence, but is this enough to ensure equitable access to life-saving technologies?
The winner will be announced live on November 9, but the real question is: How will these innovations reshape the future of heart and brain health? What do you think? Are we doing enough to bridge the gap between innovation and adoption? Share your thoughts in the comments below.
To learn more about the Health Tech Competition, visit ahahealthtech.org/aha-health-tech-competition-2025. For additional resources, including past winners and financial transparency, explore the links provided. Together, we can drive breakthroughs and transform lives—one innovation at a time.
About the American Heart Association:
For over a century, the American Heart Association has been a relentless force for longer, healthier lives. With 35 million volunteers globally, we fund research, advocate for public health, and provide critical resources to combat cardiovascular disease and stroke. Join us in our mission at heart.org.
